Diallyl Trisulfide Inhibited Tobacco Smoke-mediated Bladder EMT and Cancer Stem Cell Marker Expression Via the NF-κB Pathway
Overview
Authors
Affiliations
Objective: This study examined the effect of the NF-κB pathway on tobacco smoke-elicited bladder epithelial-mesenchymal transition (EMT) and cancer stem cell (CSC) marker expression . The effect of diallyl trisulfide (DATS) treatment was also examined.
Methods: BALB/c mice were exposed to tobacco smoke and treated with an NF-κB inhibitor and DATS. Western blotting, quantitative real-time PCR, and immunohistochemical staining were used to detect the changes of relevant indices.
Results: Phosphorylated inhibitor of kappa-B kinase alpha/beta expression and p65 and p50 nuclear transcription were increased by tobacco smoke exposure, whereas inhibitor of kappa-B expression was decreased. In addition, tobacco smoke reduced the expression of epithelial markers but increased that of mesenchymal and CSC markers. Our study further demonstrated that tobacco smoke-mediated EMT and CSC marker expression were attenuated by inhibition of the NF-κB pathway. Moreover, DATS reversed tobacco smoke-induced NF-κB pathway activation, EMT, and the acquisition of CSC properties in bladder tissues.
Conclusions: These data suggested that the NF-κB pathway regulated tobacco smoke-induced bladder EMT, CSC marker expression, and the protective effects of DATS.
Skullcapflavone II suppresses TGF-β-induced corneal epithelial mesenchymal transition .
Li M, Zhang Z, Zhang Y, Zhao F, Li Y, Dang Y Int J Ophthalmol. 2025; 18(2):209-215.
PMID: 39967985 PMC: 11754024. DOI: 10.18240/ijo.2025.02.02.
The potential of diallyl trisulfide for cancer prevention and treatment, with mechanism insights.
Lu L, Gao Z, Song J, Jin L, Liang Z Front Cell Dev Biol. 2024; 12:1450836.
PMID: 39403128 PMC: 11471646. DOI: 10.3389/fcell.2024.1450836.
Li J, Ab Rahman N, Mohamad S Cureus. 2024; 16(8):e66966.
PMID: 39280415 PMC: 11401675. DOI: 10.7759/cureus.66966.
Liu X, Wang N, He Z, Chen C, Ma J, Liu X Heliyon. 2024; 10(5):e26681.
PMID: 38434350 PMC: 10907726. DOI: 10.1016/j.heliyon.2024.e26681.
Lucchesi C, Vasilatis D, Mantrala S, Chandrasekar T, Mudryj M, Ghosh P Int J Mol Sci. 2023; 24(14).
PMID: 37511154 PMC: 10380322. DOI: 10.3390/ijms241411395.